Posts Tagged ‘Hamner’
RTP Wrapup 2/19
Thursday, February 18, 2010, 11:18 pmNovozymes says it has figured out how to make cellulosic ethanol possible that costs about the same as gasoline, GlaxoSmithKline’s restless leg drug raises safety concerns and the Hamner Institutes team up with a leading cancer cluster in Oslo, Norway. Read more…
RTP Wrapup 1/22
Thursday, January 21, 2010, 11:44 pmLiquidia Technologies in Durham gets $20 million in venture capital, b3bio, a biotech startup in Research Triangle Park, teams up with pharma giant Roche in a big way and Prolacria, Inspire Pharmaceuticals’ dry eye drug, fails yet another late-stage trial. Read more…
Roche sets up technology pipeline to RTP
Thursday, January 21, 2010, 11:23 amA biotech startup in Research Triangle Park signed a deal with pharma giant Roche that could turn the company into a brain trust of cutting-edge technologies.
Dani Bolognesi
The deal allows b3bio, a two-year-old company with 10 employees, to be Roche’s eyes and ears for new drug development and delivery technologies that are in the works at universities. Technologies that suit both partners could then be nurtured at the Hamner Institutes for Health Sciences, where b3bio has its labs, before they are turned over to Roche for further development, said Dani Bolognesi, co-founder and chief executive of b3bio. Read more…
RTP Wrapup 12/11
Friday, December 11, 2009, 12:11 amTranzyme Pharma signs on to help Bristol-Myers Squibb fight generic competition, RTI International receives a $101 million contract to fight malaria in Africa and a drug safety expert at the Hamner Institutes for Health Sciences teams up with a geneticist at N.C. State University to find out why some patients have serious liver reactions to otherwise safe drugs. Read more…
RTP looks toward China
Wednesday, November 11, 2009, 4:56 pmForty years after “Made in Japan” was synonymous with cheap, poorly made goods, Japanese technology rules the U.S. automotive industry. The same could happen with biosciences “Made in China,” just faster.
FDA exec hails new drug safety center
Thursday, June 11, 2009, 7:07 pmI was one of about two dozen visitors Thursday who took a first look at the new Hamner Institute for Drug Safety Sciences. Also among the visitors was Janet Woodcock, a Food and Drug Administration top executive who oversees the approval and regulation of all U.S. medicines. Woodcock called the opening of the 14,000-square-foot research laboratory in Research Triangle Park a “milestone in drug safety regulation.”
Gateway to China
Wednesday, May 20, 2009, 2:45 amThe Hamner Institutes of Health Sciences in Research Triangle Park has signed a deal that could help North Carolina biotech companies do business in China.
The partnership with China Medical City, a RTP-size research park the Jiangsu provincial government is establishing about three hours north of Shanghai, also aims to bring Chinese investment and jobs to North Carolina.
